IndiaTickerLatest filing: Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
ObservedCompany dossier
Gennex Laboratories
BSE:GENNEX · ISIN INE509C01026
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Gennex Laboratories
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 23.63% and public 76.37% as of 31 Mar 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
BSE · financial results
Observed
Source filing Gennex Laboratories Ltd - 531739 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Gennex Laboratories Ltd - 531739 - Closure of Trading Window
BSE · exchange filing
Observed
Source filing Gennex Laboratories Ltd - 531739 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
BSE · shareholding
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →31 Mar 2026
- Promoter group
- 23.63%
- Public
- 76.37%
- Employee trust
- N/A
Observed BSE shareholding XBRL